4.7 Article

Booster Vaccination Strategies for Living With COVID-19

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Health Care Sciences & Services

Direct and Indirect Associations of Media Use With COVID-19 Vaccine Hesitancy in South Korea: Cross-sectional Web-Based Survey

Minjung Lee et al.

Summary: This study investigated the level of COVID-19 vaccine hesitancy among the public in South Korea and identified factors associated with hesitancy. The findings revealed that sociodemographic factors, such as gender and age, and psychological factors, including perceived risk of infection and perceived benefits of vaccination, were related to vaccine hesitancy. Media use had both positive and negative effects on vaccine hesitancy, emphasizing the need for reliable and timely information dissemination.

JOURNAL OF MEDICAL INTERNET RESEARCH (2022)

Editorial Material Public, Environmental & Occupational Health

Modelling the Omicron wave in France in early 2022: Balancing herd immunity with protecting the most vulnerable

Benjamin Davido et al.

JOURNAL OF TRAVEL MEDICINE (2022)

Letter Medicine, General & Internal

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination

Rolando Pajon et al.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Multidisciplinary Sciences

Inferring the effectiveness of government interventions against COVID-19

Jan M. Brauner et al.

Summary: Research has found that closing educational institutions, limiting gathering sizes, and closing face-to-face businesses are effective nonpharmaceutical interventions in controlling the COVID-19 pandemic, while the additional effect of stay-at-home orders is relatively small.

SCIENCE (2021)

Article Immunology

The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States

Seyed M. Moghadas et al.

Summary: The study evaluated the impact of a 2-dose COVID-19 vaccination campaign in the United States on reducing the incidence, hospitalizations, and deaths. Results showed that vaccination significantly reduced the overall attack rate, with the greatest reduction observed in individuals aged 65 and older. Additionally, vaccination markedly decreased the risk of non-ICU hospitalizations, ICU hospitalizations, and deaths.

CLINICAL INFECTIOUS DISEASES (2021)

Article Medicine, General & Internal

Non-pharmaceutical interventions, vaccination, and the SARS-CoV-2 delta variant in England: a mathematical modelling study

Raphael Sonabend et al.

Summary: The study assessed the UK Government's four-step process to easing lockdown restrictions in England, taking into account the impact of the Delta variant and other factors. The findings suggest that the risk of a large wave of COVID-19 hospital admissions resulting from lifting NPIs can be mitigated but there is substantial uncertainty in the epidemic trajectory due to the emergence of the Delta variant.

LANCET (2021)

Article Medicine, General & Internal

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study

Sara Y. Tartof et al.

Summary: This study aimed to assess the overall and variant-specific effectiveness of the BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19-related hospital admissions among members of a healthcare system in California. The effectiveness of the vaccine remained high against hospital admissions even up to 6 months after full vaccination, despite a decline in effectiveness against SARS-CoV-2 infections over time, which was likely due to waning immunity rather than the delta variant escaping vaccine protection.

LANCET (2021)

Article Medicine, General & Internal

Effectiveness of a third dose of the BNT162b2 mRNA COVID-19 vaccine for preventing severe outcomes in Israel: an observational study

Noam Barda et al.

Summary: A study using data from Israel's largest health-care organization showed that a third dose of the BNT162b2 mRNA vaccine is effective in preventing individuals from severe COVID-19-related outcomes, compared to receiving only two doses at least 5 months ago. The effectiveness of the third dose in preventing hospital admission was 93%, severe disease 92%, and COVID-19-related death 81%.

LANCET (2021)

Article Multidisciplinary Sciences

Evaluation of the United States COVID-19 vaccine allocation strategy

Md Rafiul Islam et al.

Summary: This study evaluates the performance of the CDC vaccine allocation strategy with respect to multiple potentially competing vaccination goals. The CDC strategy performed well in all vaccination goals but never optimally, deviating slightly from optimal allocations. The approach developed in this study can inform the design of future vaccine allocation strategies in the United States and other countries seeking to optimize effectiveness.

PLOS ONE (2021)

Article Environmental Sciences

Vaccination Prioritization Strategies for COVID-19 in Korea: A Mathematical Modeling Approach

Yongin Choi et al.

Summary: When the vaccine supply is limited, implementing age-dependent vaccination priority strategy is important to reduce the number of deaths and incidence of infection of COVID-19. According to the study, prioritizing vaccination for the age groups with the highest transmission rates can effectively reduce the incidence, depending on the level of social distancing.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2021)

Article Public, Environmental & Occupational Health

Effectiveness of Pfizer-BioNTech and Moderna Vaccines Against COVID-19 Among Hospitalized Adults Aged ≥65 Years — United States, January–March 2021

Mark W. Tenforde et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Editorial Material Biochemistry & Molecular Biology

Understanding COVID-19 vaccine hesitancy

Shingai Machingaidze et al.

Summary: The new study reveals the complexities of COVID-19 vaccine hesitancy and acceptance in low-, middle-, and high-income countries.

NATURE MEDICINE (2021)

Article Pharmacology & Pharmacy

Demographics, comorbidities, and outcomes among young and middle-aged COVID-19 patients in Saudi Arabia

Amer S. Alali et al.

Summary: The study examined the impact of different clinical and sociodemographic variables on COVID-19 outcomes in Saudi Arabia, finding that patients with diabetes, hypertension, and pulmonary diseases were at higher risk of hospitalization and longer length of stay. Symptoms like breathlessness, loss of smell and/or taste, diarrhea, and cough were associated with a longer recovery period. Future research should explore the impact of various therapies on COVID-19 outcomes in Saudi Arabia.

SAUDI PHARMACEUTICAL JOURNAL (2021)

Article Public, Environmental & Occupational Health

New COVID-19 Cases and Hospitalizations Among Adults, by Vaccination Status — New York, May 3–July 25, 2021

Eli S. Rosenberg et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Article Immunology

Modeling the Impact of COVID-19 Vaccination in Lebanon: A Call to Speed-Up Vaccine Roll Out

Ghina R. Mumtaz et al.

Summary: Lebanon has only vaccinated 10.7% of its population against COVID-19, raising concerns about the slow vaccine rollout. Mathematical modeling shows that reaching 80% vaccine coverage by the end of 2021 can significantly reduce the severity of the epidemic, while reaching only 40% will have a lesser impact. Rapidly scaling up vaccination efforts and maintaining social distancing measures are crucial to avoid a future surge in cases that the country is unprepared for.

VACCINES (2021)

Review Medicine, General & Internal

Preparing for the Coronavirus Disease (COVID-19) Vaccination: Evidence, Plans, and Implications

Jaehun Jung

Summary: Achieving herd immunity against COVID-19 through vaccination requires high vaccination rates and public confidence in vaccine efficacy and safety, along with meticulous preparation of various components to overcome vaccine hesitancy.

JOURNAL OF KOREAN MEDICAL SCIENCE (2021)

Article Multidisciplinary Sciences

Vaccine optimization for COVID-19: Who to vaccinate first?

Laura Matrajt et al.

Summary: Vaccines are expected to be the best tool for controlling the COVID-19 pandemic, with high effectiveness paired with high coverage able to significantly mitigate the pandemic. Vaccine allocation strategies may vary based on vaccine effectiveness, with high-risk age groups prioritized for low effectiveness vaccines, and high-transmission age groups prioritized for high effectiveness vaccines.

SCIENCE ADVANCES (2021)

Review Infectious Diseases

Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis

Jing Yang et al.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)

Review Public, Environmental & Occupational Health

Predictive symptoms and comorbidities for severe COVID-19 and intensive care unit admission: a systematic review and meta-analysis

Vageesh Jain et al.

INTERNATIONAL JOURNAL OF PUBLIC HEALTH (2020)

Review Public, Environmental & Occupational Health

COVID-19 and comorbidities: Deleterious impact on infected patients

Hasan Ejaz et al.

JOURNAL OF INFECTION AND PUBLIC HEALTH (2020)

Article Biochemical Research Methods

Projecting social contact matrices in 152 countries using contact surveys and demographic data

Kiesha Prem et al.

PLOS COMPUTATIONAL BIOLOGY (2017)